The Italy acne therapeutics market is projected to grow from $241 Mn in 2022 to $390 Mn in 2030 with a CAGR of 6.2% for the year 2022-2030. The rise in disposable incomes in Italy and growing skincare concerns are the major factors driving the expansion of the market. The Italy acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. Farmabios SpA, AmypoPharma, and Allergan are some of the key players in the market.
The Italy acne therapeutics market size is at around $241 Mn in 2022 and is projected to reach $390 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period. The National Health System (NHS) expenses that the State pays to are set annually by the Finance Act of Italy at a general level of resources. The National Health Fund (NHF), which will increase from $128.73 Bn to $130.84 Bn in 2022, to $132.95 Bn in 2023, and to $135.06 Bn in 2024, has received an extra $2.11 Bn over the course of the next three years due to the 2022 Finance Act. Furthermore, the budget set aside for the acquisition of novel medications will rise by $105.52 Mn in 2022, $211.04 Mn in 2023, and $316.56 Mn in 2024.
Expanding vaccination coverage, restructuring hospital care and raising standards, revising the benefits package, and putting in place performance tracking systems for the health system are recent policy initiatives undertaken in Italy. Addressing historical underinvestment in the health workforce, updating outdated infrastructure and technology, and improving information infrastructure are key challenges for the health system. The Italian government intends to strengthen primary and community care by investing in facilities, enhancing the National Health Service (SSN) digital infrastructure, upgrading medical equipment, and funding health worker training with the help of its EU-funded National Recovery and Resilience Plan.
Acne vulgaris is a common skin condition that has a significant negative effect on the quality of life. Although it is not a fatal or disabling condition, it can be extremely painful and disfiguring, cause severe physiological distress, and place a substantial financial burden. Increases in anxiety, sadness, and suicidal thoughts are all linked to acne. According to a group of researchers headed by Dr. Luigi Naldi from the Study Center of the Italian Group for Epidemiologic Research in Dermatology in Bergamo, Italy, over 80% of teenagers experience breakouts of acne, but the majority of them see improvement in their skin after the age of 20. Depending on how severe it is, both topical and systemic therapies for acne are sometimes recommended in Italy. A retinol derivative known as isotretinoin has been used extensively to treat severe cases of acne and cases where other therapies have failed. Combination treatments, which typically combine benzoyl peroxide, retinoids, and/or antibiotics, are applied in cases of serious acne.
Market Growth Drivers
Italy is one of many countries in the world where acne is a widespread skin problem. The demand for acne therapeutics in Italy is anticipated to increase as acne becomes more common. The Italy acne therapeutics market is anticipated to increase as the general population's disposable income rises because patients may be inclined to spend money on expensive treatments. The demand for acne therapeutics is anticipated to increase as skincare and attractiveness become more important in Italy.
The adverse effects of acne treatments, such as skin irritation, dryness, and redness, may prevent patients from using them. The use of alternative therapies by patients, such as over-the-counter medicines, natural therapies, or household remedies, may reduce the demand in Italy's acne therapeutics market.
The governmental organization in charge of drug regulation in Italy since 2004 is the Italian Medicines Agency (Agenzia Italiana del Farmaco, or AIFA). Under the guidance of the Ministry of Health and under the close supervision of the Ministries of Health and Economy, the AIFA is a public organization that operates in accordance with the principles of autonomy, transparency, and efficiency. It assures the availability of medications, their safe and effective use as a tool for health protection, and the national coherence of the pharmaceutical system in accordance with the regions. It also ensures that pharmaceutical spending is governed in a manner that promotes the pharmaceutical sector's viability and compatibility with economic and financial factors. AIFA is especially concerned about the problem of counterfeit medicines. As the head of two Council of Europe (CoE) - EDQM Committees (CD-P-P and CMED), the AIFA Counterfeit Prevention Unit oversees numerous foreign projects.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
22.214.171.124 Product Applications and Services
126.96.36.199 Recent Developments
188.8.131.52 Partnerships Ecosystem
184.108.40.206 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Treatment (Revenue, USD Billion):
By Route of Administration (Revenue, USD Billion):
By Age Group (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses